vs

Side-by-side financial comparison of Armour Residential REIT, Inc. (ARR) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

Armour Residential REIT, Inc. is the larger business by last-quarter revenue ($50.4M vs $41.8M, roughly 1.2× Neuronetics, Inc.). Armour Residential REIT, Inc. runs the higher net margin — 420.2% vs -17.2%, a 437.5% gap on every dollar of revenue. On growth, Armour Residential REIT, Inc. posted the faster year-over-year revenue change (297.9% vs 85.7%). Over the past eight quarters, Armour Residential REIT, Inc.'s revenue compounded faster (108.0% CAGR vs 54.9%).

Armour Residential REIT, Inc. is a U.S.-based real estate investment trust that primarily invests in agency residential mortgage-backed securities guaranteed by U.S. government-sponsored entities. It focuses on generating consistent long-term net income for shareholders via strategic asset management and active interest rate risk mitigation.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

ARR vs STIM — Head-to-Head

Bigger by revenue
ARR
ARR
1.2× larger
ARR
$50.4M
$41.8M
STIM
Growing faster (revenue YoY)
ARR
ARR
+212.1% gap
ARR
297.9%
85.7%
STIM
Higher net margin
ARR
ARR
437.5% more per $
ARR
420.2%
-17.2%
STIM
Faster 2-yr revenue CAGR
ARR
ARR
Annualised
ARR
108.0%
54.9%
STIM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARR
ARR
STIM
STIM
Revenue
$50.4M
$41.8M
Net Profit
$211.7M
$-7.2M
Gross Margin
52.0%
Operating Margin
-12.1%
Net Margin
420.2%
-17.2%
Revenue YoY
297.9%
85.7%
Net Profit YoY
555.9%
43.2%
EPS (diluted)
$2.43
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARR
ARR
STIM
STIM
Q4 25
$50.4M
$41.8M
Q3 25
$38.5M
$37.3M
Q2 25
$33.1M
$38.1M
Q1 25
$36.3M
$32.0M
Q4 24
$12.7M
$22.5M
Q3 24
$18.5M
Q2 24
$7.0M
$16.4M
Q1 24
$17.4M
Net Profit
ARR
ARR
STIM
STIM
Q4 25
$211.7M
$-7.2M
Q3 25
$159.3M
$-9.0M
Q2 25
$-75.6M
$-10.1M
Q1 25
$27.3M
$-12.7M
Q4 24
$-46.4M
$-12.7M
Q3 24
$-13.3M
Q2 24
$-48.4M
$-9.8M
Q1 24
$-7.9M
Gross Margin
ARR
ARR
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
ARR
ARR
STIM
STIM
Q4 25
-12.1%
Q3 25
-19.6%
Q2 25
-21.1%
Q1 25
-34.4%
Q4 24
-51.0%
Q3 24
-41.7%
Q2 24
-51.7%
Q1 24
-39.4%
Net Margin
ARR
ARR
STIM
STIM
Q4 25
420.2%
-17.2%
Q3 25
413.5%
-24.3%
Q2 25
-228.4%
-26.6%
Q1 25
75.2%
-39.6%
Q4 24
-366.8%
-56.4%
Q3 24
-72.0%
Q2 24
-693.8%
-59.8%
Q1 24
-45.2%
EPS (diluted)
ARR
ARR
STIM
STIM
Q4 25
$2.43
$-0.10
Q3 25
$1.49
$-0.13
Q2 25
$-0.94
$-0.15
Q1 25
$0.32
$-0.21
Q4 24
$-0.91
$-0.34
Q3 24
$-0.44
Q2 24
$-1.05
$-0.33
Q1 24
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARR
ARR
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$63.3M
$28.1M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$2.3B
$22.4M
Total Assets
$21.0B
$141.6M
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARR
ARR
STIM
STIM
Q4 25
$63.3M
$28.1M
Q3 25
$44.2M
$28.0M
Q2 25
$141.2M
$11.0M
Q1 25
$49.1M
$20.2M
Q4 24
$68.0M
$18.5M
Q3 24
$20.9M
Q2 24
$126.6M
$42.6M
Q1 24
$47.7M
Total Debt
ARR
ARR
STIM
STIM
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Q1 24
$59.4M
Stockholders' Equity
ARR
ARR
STIM
STIM
Q4 25
$2.3B
$22.4M
Q3 25
$2.1B
$27.4M
Q2 25
$1.7B
$27.1M
Q1 25
$1.7B
$35.5M
Q4 24
$1.4B
$27.7M
Q3 24
$9.4M
Q2 24
$1.2B
$19.4M
Q1 24
$27.7M
Total Assets
ARR
ARR
STIM
STIM
Q4 25
$21.0B
$141.6M
Q3 25
$19.4B
$145.5M
Q2 25
$16.2B
$134.7M
Q1 25
$15.5B
$142.0M
Q4 24
$13.5B
$140.9M
Q3 24
Q2 24
$10.1B
$96.8M
Q1 24
$103.8M
Debt / Equity
ARR
ARR
STIM
STIM
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARR
ARR
STIM
STIM
Operating Cash FlowLast quarter
$124.2M
$908.0K
Free Cash FlowOCF − Capex
$692.0K
FCF MarginFCF / Revenue
1.7%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
0.59×
TTM Free Cash FlowTrailing 4 quarters
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARR
ARR
STIM
STIM
Q4 25
$124.2M
$908.0K
Q3 25
$-37.8M
$-785.0K
Q2 25
$25.0M
$-3.5M
Q1 25
$101.5M
$-17.0M
Q4 24
$261.5M
$-8.6M
Q3 24
$-5.4M
Q2 24
$27.1M
$-5.0M
Q1 24
$-12.0M
Free Cash Flow
ARR
ARR
STIM
STIM
Q4 25
$692.0K
Q3 25
$-899.0K
Q2 25
$-3.8M
Q1 25
$-17.2M
Q4 24
$-8.7M
Q3 24
$-5.8M
Q2 24
$-5.6M
Q1 24
$-12.4M
FCF Margin
ARR
ARR
STIM
STIM
Q4 25
1.7%
Q3 25
-2.4%
Q2 25
-9.9%
Q1 25
-53.8%
Q4 24
-38.6%
Q3 24
-31.3%
Q2 24
-34.0%
Q1 24
-71.1%
Capex Intensity
ARR
ARR
STIM
STIM
Q4 25
0.5%
Q3 25
0.3%
Q2 25
0.7%
Q1 25
0.7%
Q4 24
0.4%
Q3 24
2.1%
Q2 24
3.7%
Q1 24
2.2%
Cash Conversion
ARR
ARR
STIM
STIM
Q4 25
0.59×
Q3 25
-0.24×
Q2 25
Q1 25
3.71×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons